secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001193125-24-161591
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclerion Therapeutics shareholders re-elect all five directors, ratify Ernst & Young as auditor
--------------------------------------------------------------------------------

- Each of five director nominees (De Souza, Hecht, Hyman, Higgins, Katabi) elected with for votes ranging from 1,670,155 to 1,688,966.
- Ernst & Young ratified as independent auditor for FY 2024 with 2,140,990 votes for, 47,974 against, 8,751 abstain.
- Proposal to adjourn annual meeting if necessary approved with 2,111,217 for, 86,202 against, 296 abstain.
- Broker non-votes on director election were 454,351 for each nominee; no other proposals had broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000119312524161591/0001193125-24-161591-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000119312524161591/d811748d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-161591

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer